Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Catalent, Inc. Common Stock (NY:CTLT)

63.48 UNCHANGED
Last Price Updated: 7:00 PM EST, Dec 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Catalent, Inc. Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Catalent, Inc. (CTLT) Investors
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Catalent, and Tesla and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Catalent, Inc. (CTLT) Investors
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Bronstein, Gewirtz & Grossman, LLC Notifies Catalent, Inc. (CTLT) Investors of Class Action and to Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
News headline image
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Catalent, Inc. (CTLT) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Catalent, Inc. (CTLT) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Catalent Publishes Fourth Annual Corporate Responsibility Report Highlighting Achievements While Providing New Record Number of Patient Treatments
From Catalent, Inc.
Via Business Wire
News headline image
CATALENT SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess Of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Catalent, Inc. - CTLT
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Catalent, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – CTLT
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
INVESTOR DEADLINE: Catalent, Inc. Investors with Substantial Losses Have Opportunity to Lead the Catalent Class Action Lawsuit – CTLT
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
News headline image
The Law Offices of Frank R. Cruz Announces Investigation of Catalent, Inc. (CTLT) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Catalent, Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Catalent, Inc. (CTLT)
From Robbins LLP
Via Business Wire
News headline image
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Catalent, Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
Labaton Sucharow LLP Announces Securities Class Action Lawsuit Filed Against Catalent, Inc. and Certain Executives
From Labaton Sucharow LLP
Via Business Wire
News headline image
The Large Cap Rally Is Largely About These 3 Stocks
With a combined weighting of more than 4%, it’s strength in these three tickers that have much to do with the S&P’s 2023 performance. 
Via MarketBeat
Topics Economy Stocks
News headline image
Catalent Appoints Joseph A. Ferraro as Senior Vice President, General Counsel, Chief Compliance Officer, and Secretary
From Catalent, Inc.
Via Business Wire
News headline image
Catalent, Inc. Reports Second Quarter Fiscal 2023 Results
From Catalent, Inc.
Via Business Wire
News headline image
Catalent, Inc. Announces Second Quarter Fiscal Year 2023 Earnings Conference Webcast
From Catalent, Inc.
Via Business Wire
News headline image
Catalent Appoints Ricardo Zayas as North American Biologics Operations Leader
From Catalent, Inc.
Via Business Wire
News headline image
Sarepta and Catalent Expand Strategic Manufacturing Partnership With Commercial Supply Agreement for Duchenne Muscular Dystrophy Gene Therapy Candidate
From Catalent, Inc.
Via Business Wire
News headline image
Catalent, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Catalent, Inc.
Via Business Wire
News headline image
Catalent Announces Changes to its Board of Directors
From Catalent, Inc.
Via Business Wire
News headline image
After a $100 Haircut, is Catalent an Oversold Pharma Play?
With the macro backdrop weakening for Catalent’s pharmaceutical and biotech customers, fundamental concerns could outweigh what the charts suggest. 
Via MarketBeat
News headline image
Catalent, Inc. to Present at the Stephens Annual Investment Conference
From Catalent, Inc.
Via Business Wire
News headline image
Exelixis and Catalent Enter into New License Agreement for Three Antibody-Drug Conjugate Programs with the Potential to Accelerate Exelixis’ Biologics Pipeline
From Exelixis, Inc.
Via Business Wire
News headline image
Catalent, Inc. Reports First Quarter Fiscal 2023 Results
From Catalent, Inc.
Via Business Wire
News headline image
Catalent, Inc. Announces First Quarter Fiscal Year 2023 Earnings Conference Webcast
From Catalent, Inc.
Via Business Wire
News headline image
Catalent, Inc. to Present at September Investor Conferences
From Catalent, Inc.
Via Business Wire
News headline image
Catalent, Inc. Reports Fourth Quarter Fiscal 2022 Results
From Catalent, Inc.
Via Business Wire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.